(Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | (Q3)Oct 31, 2023 | (Q2)Jul 31, 2023 | (Q1)Apr 30, 2023 | (FY)Jan 31, 2023 | (Q4)Jan 31, 2023 | (Q3)Oct 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -867.65%-1.28M | -29.58%-569.11K | 54.67%-3.34M | -164.64%-1.43M | -286.57%-1.64M | 106.93%167.24K | 88.98%-439.18K | -229.35%-7.36M | -7.28%-539.31K | -423.8K |
Net income from continuing operations | 45.68%-2.47M | -6.57%-2.47M | 11.03%-10.62M | -236.16%-1.04M | 22.70%-2.72M | -58.35%-4.54M | 63.19%-2.32M | -7.83%-11.94M | 114.61%760.43K | ---3.52M |
Operating gains losses | ---- | ---- | 93.32%-87.97K | ---- | ---- | ---- | ---- | -173.24%-1.32M | ---- | ---- |
Depreciation and amortization | -6.70%863.01K | 10.97%939.54K | 10.40%3.62M | 5.92%962.09K | -30.24%886.73K | 77.22%924.99K | 46.50%846.7K | 25.21%3.28M | 17.96%908.35K | --1.27M |
Asset impairment expenditure | -191.33%-209.8K | 519.69%67.96K | 152.77%142.5K | 75.15%-240.12K | -26.58%141.93K | -54.31%229.72K | --10.97K | -139.34%-270.06K | -240.74%-966.15K | --193.31K |
Remuneration paid in stock | -51.50%102.93K | -85.94%28.98K | -46.19%855.53K | -45.73%224.95K | -48.00%212.21K | -46.50%212.21K | -44.39%206.18K | --1.59M | --414.46K | --408.09K |
Other non cashItems | -60.41%759.88K | 329.41%798.43K | -56.40%1.93M | -367.97%-518.14K | 84.28%344.03K | 984.56%1.92M | -95.20%185.94K | 147.08%4.43M | -66.53%193.36K | --186.69K |
Change In working capital | -121.85%-327.5K | -88.81%70.89K | 126.29%824.15K | -51.85%-809.57K | -147.91%-498.56K | 230.91%1.5M | 125.37%633.45K | -261.46%-3.13M | -160.20%-533.12K | --1.04M |
-Change in receivables | -449.21%-223.46K | -212.03%-49.58K | 26.35%-172.99K | 82.60%-80.74K | -116.12%-35.67K | -186.98%-40.69K | 59.20%-15.89K | 66.20%-234.88K | -361.70%-464.06K | --221.35K |
-Change in inventory | -652.35%-1.19M | -179.00%-720.46K | 89.95%-133.5K | -138.53%-271.41K | -142.46%-615.67K | 85.49%-158.36K | 232.58%911.95K | -230.42%-1.33M | -0.24%704.5K | ---253.92K |
-Change in prepaid assets | -948.82%-531.14K | -217.16%-110.5K | 153.16%59.24K | -77.15%53.21K | -181.78%-150.87K | 110.75%62.57K | 77.33%94.32K | 51.20%-111.44K | 285.09%232.87K | --184.49K |
-Change in payables and accrued expense | -1.03%1.62M | 366.57%951.43K | 173.42%1.07M | 46.78%-535.6K | -63.03%328.61K | 239.31%1.64M | 80.43%-356.92K | -179.06%-1.46M | -887.30%-1.01M | --888.77K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -867.65%-1.28M | -29.58%-569.11K | 54.67%-3.34M | -164.64%-1.43M | -286.57%-1.64M | 106.93%167.24K | 88.98%-439.18K | -229.35%-7.36M | -7.28%-539.31K | ---423.8K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 92.71%-4.7K | 71.41%-62.08K | 8.11%-1.17M | -1,972.77%-378K | -346.32%-512.41K | 56.65%-64.47K | 78.96%-217.17K | 46.60%-1.28M | -86.51%20.18K | -114.81K |
Net PPE purchase and sale | 89.86%-4.4K | 92.04%-17.25K | 10.50%-1.14M | -1,788.96%-373.23K | -358.04%-506.13K | 69.76%-43.36K | 79.19%-216.73K | 46.34%-1.27M | -85.22%22.1K | ---110.5K |
Net intangibles purchas and sale | 98.57%-302 | -10,182.80%-44.83K | -162.01%-32.59K | -149.37%-4.77K | -45.71%-6.28K | -297.81%-21.11K | 52.19%-436 | 21.92%-12.44K | -2,136.17%-1.91K | ---4.31K |
Net business purchase and sale | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --10.06K | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 92.71%-4.7K | 71.41%-62.08K | 8.11%-1.17M | -1,972.77%-378K | -346.32%-512.41K | 56.65%-64.47K | 78.96%-217.17K | 46.60%-1.28M | -86.51%20.18K | ---114.81K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 96.98%911.38K | 260.70%974.42K | -52.19%2.34M | -66.14%677.11K | 447.64%1.81M | 229.59%462.67K | -116.09%-606.35K | -53.00%4.89M | -67.36%2M | -519.22K |
Net issuance payments of debt | -47.30%954.41K | 262.93%987.91K | 221.11%2.31M | -25.69%-692.34K | 442.95%1.8M | 559.01%1.81M | -38.48%-606.35K | -137.87%-1.91M | -249.19%-550.85K | ---524.22K |
Net common stock issuance | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --6.69M | --2.93M | --0 |
Proceeds from stock option exercised by employees | --0 | --9.72K | -74.85%28.43K | 100.00%-1 | 44.00%7.2K | -43.38%21.23K | --0 | 90.18%113.06K | ---944.94K | --5K |
Net other financing activities | ---43.04K | ---23.21K | ---- | ---- | ---2 | ---- | ---- | ---- | ---- | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 96.98%911.38K | 260.70%974.42K | -52.19%2.34M | -66.14%677.11K | 447.64%1.81M | 229.59%462.67K | -116.09%-606.35K | -53.00%4.89M | -67.36%2M | ---519.22K |
Net cash flow | ||||||||||
Beginning cash position | -29.81%1.26M | -70.14%901.55K | -51.50%3.02M | 123.28%2.2M | 12.21%2.47M | -64.04%1.79M | -51.50%3.02M | 869.21%6.23M | 51.00%983.17K | --2.2M |
Current changes in cash | -166.70%-377.17K | 127.18%343.24K | 42.06%-2.17M | -176.18%-1.13M | 67.32%-345.66K | 119.36%565.45K | -1.06%-1.26M | -164.78%-3.75M | -74.35%1.48M | ---1.06M |
Effect of exchange rate changes | -118.13%-19.8K | -60.92%14.75K | -90.17%53.11K | -129.81%-165.59K | 145.01%71.77K | -16.00%109.19K | 166.52%37.74K | 370.17%540.11K | 379.61%555.43K | ---159.47K |
End cash Position | -65.07%862.56K | -29.81%1.26M | -70.14%901.55K | -70.14%901.55K | 123.28%2.2M | 12.21%2.47M | -64.04%1.79M | -51.50%3.02M | -51.50%3.02M | --983.17K |
Free cash from | -1,353.72%-1.29M | 3.83%-631.19K | 47.86%-4.51M | -247.74%-1.81M | -299.31%-2.15M | 104.01%102.78K | 86.94%-656.35K | -87.02%-8.65M | -47.04%-519.13K | ---538.61K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data